Platelet-activating factor mediated potentiation of stimulation-evoked catecholamine release and the rise in intracellular free Ca2+ concentration in adrenal chromaffin cells.

[1]  Kunio Kato,et al.  Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation , 1994, Nature.

[2]  T. Yue,et al.  Platelet-activating factor inhibits excitatory transmission in rat neostriatum , 1993, Neuroscience Letters.

[3]  M. V. Hogan,et al.  Long-term potentiation in the hippocampus induced by platelet-activating factor , 1993, Neuron.

[4]  C. Zorumski,et al.  Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor , 1992, Neuron.

[5]  A. Ogura,et al.  Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons , 1992, Neuron.

[6]  N. Nathan,et al.  Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus. , 1992, Diabete & metabolisme.

[7]  K. Morita,et al.  Mechanism of cyclic AMP facilitation of stimulation-evoked catecholamine release in adrenal chromaffin cells—I. Evidence for enhancement of evoked increase in cytosolic free Na+ concentration by cyclic AMP elevation , 1991, Neurochemistry International.

[8]  K. Morita,et al.  Mechanism of cyclic AMP facilitation of stimulation-evoked catecholamine release in adrenal chromaffin cells—II. Inhibition of Na+,K+-ATPase by cyclic AMP , 1991, Neurochemistry International.

[9]  T. Yue,et al.  Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells , 1991, Neuroscience.

[10]  H. Bito,et al.  Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. , 1991, The Journal of biological chemistry.

[11]  K. Morita,et al.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells. , 1991, The Biochemical journal.

[12]  T. Yue,et al.  Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. , 1991, The Journal of pharmacology and experimental therapeutics.

[13]  H. Heuer,et al.  Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia. , 1991, Biochemical pharmacology.

[14]  Takao Shimizu,et al.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.

[15]  P. Braquet,et al.  Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. , 1990, The Journal of biological chemistry.

[16]  C. Rossberg,et al.  PAF Antagonist Ginkgolide B Reduces Postischemic Neuronal Damage in Rat Brain Hippocampus , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  T. Ogihara,et al.  Direct evidence of elevated levels of circulating platelet-activating factor in a patient with disseminated intravascular coagulation syndrome. , 1989, Journal of lipid mediators.

[18]  A. M. Camoratto,et al.  Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro. , 1989, Endocrinology.

[19]  P. Braquet,et al.  Platelet‐Activating Factor Antagonist BN52021 Decreases Accumulation of Free Polyunsaturated Fatty Acid in Mouse Brain During Ischemia and Electroconvulsive Shock , 1988, Journal of neurochemistry.

[20]  D. Hanahan,et al.  Production and effects of platelet-activating factor in the rat brain. , 1988, Biochimica et biophysica acta.

[21]  P. Braquet,et al.  Platelet activating factor induces dopamine release in PC-12 cell line. , 1988, The American journal of physiology.

[22]  M. Junier,et al.  Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. , 1988, Endocrinology.

[23]  Y. Ehrlich,et al.  Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. , 1988, Science.

[24]  P. Braquet,et al.  Presence of specific binding sites for platelet-activating factor (PAF) in brain. , 1988, Biochemical and biophysical research communications.

[25]  P. Braquet,et al.  Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. , 1987, Biochemical and biophysical research communications.

[26]  P. Kochanek,et al.  Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. , 1987, Life sciences.

[27]  K. Morita,et al.  Enhancement of Stimulation‐Evoked Catecholamine Release from Cultured Bovine Adrenal Chromaffin Cells by Forskolin , 1987, Journal of neurochemistry.

[28]  D. Hanahan,et al.  Alkylacetylglycerophosphocholine stimulates Na+-Ca2+ exchange, protein phosphorylation and polyphosphoinositide turnover in rat ileal plasmalemmal vesicles. , 1986, Biochimica et biophysica acta.

[29]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[30]  H. Söling,et al.  Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands. , 1984, European journal of biochemistry.

[31]  U. S. Euler,et al.  Improved technique for the fluorimetric estimation of catecholamines. , 1961, Acta physiologica Scandinavica.